Sodium butyrate modulates necroptosis in intestinal epithelial cells during liver cirrhosis, offering potential therapeutic ...

Microbiotica, a clinical-stage biopharma company developing a pipeline of oral precision microbiome medicines called live biotherapeutic products (LBPs), announces that the first patient has been ...

"Breast milk, with its thousands of bioactive compounds, has the potential to influence the development of the infant's epithelial barriers and immune cells ... making it vulnerable to infection, ...